# FDA Inspection 971707 - Douglas Glenn Young, M.D. - May 13, 2016

Source: https://www.keypedia.com/records/fda_inspections/douglas-glenn-young-md/367df24e-a82b-40d2-8476-a4abf8a8ed32
Source feed: FDA_Inspections

> FDA Inspection 971707 for Douglas Glenn Young, M.D. on May 13, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 971707
- Company Name: Douglas Glenn Young, M.D.
- Inspection Date: 2016-05-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1223258 - 2023-11-20](https://www.keypedia.com/records/fda_inspections/douglas-glenn-young-md/ed5efc59-1160-4bad-99c4-1647cd555b0a)
- [FDA Inspection 708204 - 2011-02-03](https://www.keypedia.com/records/fda_inspections/douglas-glenn-young-md/140a0817-3718-446f-8b29-3f775c7a1363)
- [FDA Inspection 673350 - 2010-07-07](https://www.keypedia.com/records/fda_inspections/douglas-glenn-young-md/12a8cc78-dcb7-4a16-942e-7a77684698b0)
- [FDA Inspection 614235 - 2009-09-24](https://www.keypedia.com/records/fda_inspections/douglas-glenn-young-md/cd68ee39-0ff8-4e41-9523-1da6f39ca058)

Company: https://www.keypedia.com/companies/douglas-glenn-young-md/8df28cec-c379-4bbf-a055-6f2996fa1da3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c